"Novel Biomarker for Assessing Infant Stress and Developmental Risks"

Researchers have discovered a biomarker, F2-isoprostane, that can predict the impact of early toxic stress on infant cognitive development and health. This biomarker showed a strong correlation with cognitive development in infants as young as one year old, providing a critical tool for early intervention in at-risk infants. The study followed 116 pairs of mothers and their infants and found that higher levels of F2-isoprostane in infants correlated with lower cognitive development scores at one year old. This breakthrough offers new insights into child development and the potential for altering life trajectories.